TrialClinical pharmacokinetics2024

Population Pharmacokinetic Analysis of Tucatinib in Healthy Participants and Patients with Breast Cancer or Colorectal Cancer.

Daping Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.